RxDoctor Payments Data

Megan Fisher, APRN

Family · Owensboro, KYNPI 1548849144

Payments from drug & device makers

$8,526in general payments, 2019–2025

Across 479 payments — averaging $17.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$834
  • E.r. Squibb & Sons, L.L.C.$689
  • Daiichi Sankyo Inc.$523
  • AstraZeneca$505
  • Pfizer$492
  • Johnson & Johnson$486
  • plus $5K from 54 others

What the payments were for

  • Food & beverage$7,94693%
  • Education$5807%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis60$834
E.r. Squibb & Sons, L.L.C.36$689
Daiichi Sankyo Inc.31$523
AstraZeneca(2 entities)24$505
Pfizer33$492
Johnson & Johnson23$486
Merck25$401
AbbVie20$353
Bristol Myers Squibb18$324
Amgen17$282
Astellas Pharma US Inc16$248
Seagen Inc.15$243
Myriad Genetic Laboratories, Inc.4$238
Takeda Pharmaceuticals U.S.A., Inc.10$224
Incyte Corporation9$216
Sanofi11$202
Regeneron Healthcare Solutions, Inc.8$143
AVEO Pharmaceuticals, Inc.7$135
GSK6$113
Kyowa Kirin, Inc.6$112
Tersera Therapeutics LLC6$107
Genentech USA, Inc.6$104
Pharmaessentia USA Corporation5$101
Boehringer Ingelheim5$98
Sobi, Inc4$86
Coherus Oncology, Inc.5$80
Gilead4$77
Pharmacyclics LLC, An Abbvie Company5$73
Puma Biotechnology, Inc.4$65
EMD Serono, Inc.3$61
Array Biopharma Inc4$58
Cumberland Pharmaceuticals, Inc.3$57
Bayer4$56
Iovance Biotherapeutics, Inc.4$49
Lilly USA, LLC3$44
Stemline Therapeutics Inc.2$42
Celltrion USA Inc.2$40
Blue Earth Diagnostics2$40
Blueprint Medicines Corporation2$37
Clovis Oncology, Inc.2$35
Beone Medicines USA, Inc.2$34
Shield Therapeutics Inc1$31
ADC Therapeutics America, Inc.2$30
Genmab U.S., Inc.1$30
Ipsen Biopharmaceuticals, Inc2$29
Foundation Medicine, Inc.2$27
Sumitomo Pharma America, Inc.1$26
Monteris Medical Corporation1$25
Sun Pharmaceutical Industries Inc.1$23
Mirati Therapeutics, Inc.1$22
Azurity Pharmaceuticals, Inc.1$20
Karyopharm Therapeutics Inc.1$19
Eisai Inc.1$18
AMAG Pharmaceuticals, Inc.1$18
Syndax Pharmaceuticals, Inc.1$17
G1 Therapeutics, Inc.1$17
Accord Healthcare, Inc.1$16
Novocure Inc.1$14
Harmony Biosciences LLC1$14
Rigel Pharmaceuticals, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,526 in reported general payments places this provider in the 95th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$12,713
Medicare patients
77
Services billed
129

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron21$441
Prochlorperazine Maleate17$310
Dexamethasone21$144
Hydroxyurea16$137
Anastrozole13$116

Paid to pharmacies, not to this prescriber.

Other family in Owensboro

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →